Immuneering Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +338.7% | +100.6% | +74.3% | +27.0% | +9.4% | -8.1% | |
| – | +82.2% | +65.9% | +125.5% | +40.9% | +13.5% | -2.9% | |
| – | -61.3% | +37.6% | +172.2% | – | – | – | |
| – | +186.6% | -28.1% | +90.7% | -156.8% | – | – | |
| – | +160.2% | +13.8% | +1,121.5% | -53.8% | -75.2% | +67.6% | |
| – | +160.2% | +141,463.2% | – | -82.6% | +262.3% | -435.7% | |
| – | – | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | +121.2% | +279.8% | -100.0% | +149,558.4% | -81.4% | +4,172.3% | |
| – | +83.4% | +62.2% | -106.0% | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.